Clinical Trial Update: Glutathione in Mild Cognitive Impairment [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating glutathione for Mild Cognitive Impairment is ongoing. The trial status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Glutathione (glutathione)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Mild Cognitive Impairment | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING